A U.S. judge said on Tuesday that Novo Nordisk must face part of a lawsuit accusing it of defrauding shareholders about a clinical trial for its weight loss and diabetes treatment CagriSema. Novo Nordisk’s American depositary receipts fell 17.8% on …
AI Accelerates Cyber Threat Landscape, Poses New Risks for Insurers and Businesses
Industry executives speaking during a recent NetDiligence Cyber Risk Summit in Philadelphia said cyber losses are increasingly driven by operational disruptions, sophisticated fraud schemes, rather